NCT07528586 2026-04-14
CMR-Onko
Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF)
Phase NA Recruiting
Clinical Trials
206 trialsNCT07515859 2026-04-13
Risk Stratification of Cancer Therapy-Related Cardiac Dysfunction Using AI-Enhanced Electrocardiography
Yonsei University
Completed
NCT06183437 2026-03-30
STOP-MED CTRCD
University Health Network, Toronto
Phase 4 Recruiting
NCT06778122 2026-03-27
BREATHS
University College, London
Phase NA Recruiting
NCT05096338 2026-03-23
PCT
Abramson Cancer Center at Penn Medicine
Active not recruiting
NCT06211413 2026-03-23
SENTINEL
Abramson Cancer Center at Penn Medicine
Enrolling by invitation
NCT07191730 2026-03-19
ML-CardioTox
University Hospital, Caen
Recruiting
NCT07442578 2026-03-18
PULSE
Dana-Farber Cancer Institute
Phase NA Active not recruiting
NCT06277388 2026-03-11
Evaluation of Impedance Cardiography for Assessing Hemodynamic Shifts in Patients With LA-NSCLC During Treatment.
Sun Yat-sen University
Active not recruiting
NCT04827563 2026-03-04
Dyspnea and Cardiotoxicity in Multiple Myeloma Patients Who Receive Carfilzomib
University of Chicago
Terminated
NCT06844669 2026-03-03
HER2HEART-US: Prevention of Cardiotoxicity in Breast Cancer Patients Receiving HER2-directed Therapy
Washington University School of Medicine
Phase 2 Active not recruiting
NCT07158450 2026-02-25
NOECHO
Skribe Medical
Enrolling by invitation
NCT07405385 2026-02-12
CARE-BREAST
University of Castilla-La Mancha
Phase NA Not yet recruiting
NCT04026737 2026-02-09
CVE-CART
Abramson Cancer Center at Penn Medicine
Completed
NCT04361240 2026-02-09
Cardiotoxicity in Breast Cancer Patients Treated With Proton or Photon Radiotherapy: A RadComp Companion Study
Abramson Cancer Center at Penn Medicine
Completed
NCT06332131 2026-02-09
Effects of Immune Checkpoint Inhibitors on Coronary Microvasculature
Abramson Cancer Center at Penn Medicine
Enrolling by invitation
NCT06443645 2026-02-04
SCARA-B
Centre Paul Strauss
Recruiting
NCT04044872 2026-02-02
Hyperpolarized Carbon 13-Based Metabolic Imaging to Detect Radiation-Induced Cardiotoxicity
University of Texas Southwestern Medical Center
Phase EARLY_PHASE1 Terminated
NCT04928261 2026-01-22
Evaluating 6-months of HER2-targeted Therapy in Patients With HER2 Positive Early-stage Breast Cancer That Achieve a Pathological Complete Response to Neoadjuvant Systemic Therapy
Ottawa Hospital Research Institute
Phase 4 Active not recruiting
NCT06595147 2026-01-08
BE-FITTER
University of Alberta
Phase NA Recruiting
NCT06220032 2026-01-05
HO170DLBCL
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3 Recruiting
NCT06023576 2026-01-02
A Study of Blood Pressure Control During Cancer Treatment
Memorial Sloan Kettering Cancer Center
Phase 2 Recruiting
NCT07299812 2025-12-23
BRAVE-HEART
Fondazione IRCCS Policlinico San Matteo di Pavia
Recruiting
NCT02696707 2025-12-18
OTT 15-05
Ottawa Hospital Research Institute
Phase 4 Completed
NCT07254221 2025-12-10
ROSUBREAST
Shiraz University of Medical Sciences
Phase 4 Not yet recruiting
NCT07267247 2025-12-05
Cancer Therapy-Related Cardiac Dysfunction Associated With EGFR-TKIs in Advanced EGFR-mutant Non-small Cell Lung Cancer
Taichung Veterans General Hospital
Completed
NCT04598646 2025-12-03
HIMALAYAS-P
University Health Network, Toronto
Phase NA Completed
NCT05023785 2025-11-26
HIMALAYAS
University Health Network, Toronto
Phase NA Recruiting
NCT05271162 2025-11-21
EMPACT
Maria Sklodowska-Curie National Research Institute of Oncology
Phase 3 Recruiting
NCT03787966 2025-11-19
ATOPE
Universidad de Granada
Phase NA Completed
NCT02916316 2025-11-18
Study Investigating the Cardiotoxicity of Anthracyclines in Patients With Diffuse Large B-Cell
Fondazione Italiana Linfomi - ETS
Completed
NCT04790266 2025-11-18
CARDIOTOX
Oncology Institute of Southern Switzerland
Completed
NCT05559164 2025-11-14
Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted
Rutgers, The State University of New Jersey
Phase 2 Recruiting
NCT05078190 2025-11-06
CCT2
Abramson Cancer Center at Penn Medicine
Active not recruiting
NCT04036032 2025-10-14
Role of Aerobic Exercise to Modulate Cardiotoxicity in Long Term Cancer Survivors Exposed to Anthracycline Therapy
Connecticut Children's Medical Center
Completed
NCT05377320 2025-10-14
PAtient Similarity for Decision-Making in Prevention of Cardiovascular Toxicity (PACT): A Feasibility Study
Medical College of Wisconsin
Not yet recruiting
NCT04023110 2025-10-09
CCTGuide Pilot
Abramson Cancer Center at Penn Medicine
Phase 1 Completed
NCT03418961 2025-10-08
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
SWOG Cancer Research Network
Phase 3 Recruiting
NCT04305613 2025-10-02
CLARITY
Abramson Cancer Center at Penn Medicine
Active not recruiting
NCT06605833 2025-10-01
CARD-IO
Royal Marsden NHS Foundation Trust
Enrolling by invitation
NCT05036252 2025-09-30
Study of Cardiopulmonary Exercise Testing in Women Who Have HER2-Positive Breast Cancer With Mild Cardiotoxicity
Memorial Sloan Kettering Cancer Center
Active not recruiting
NCT06888505 2025-09-18
DAPA-AIC
Hawler Medical University
Phase 2 Completed
NCT06350994 2025-09-02
Cardio CAR-T
Assistance Publique - Hôpitaux de Paris
Recruiting
NCT06155331 2025-08-19
Evaluation of Possible Safety and Efficacy of Fenofibrate in the Prophylaxis of Doxorubicin Induced Cardiotoxicity in Breast Cancer Patients
Tanta University
Phase 2 Completed
NCT04892667 2025-08-13
DETECT
Assistance Publique - Hôpitaux de Paris
Phase NA Active not recruiting
NCT06132984 2025-08-01
Cardiac Magnetic Resonance Monitoring of Immune Checkpoint Inhibitor-related Cardiotoxicity
West China Second University Hospital
Recruiting
NCT03862131 2025-07-29
PROACT
Washington University School of Medicine
Phase 2 Terminated
NCT02772367 2025-07-16
Generation of Heart Muscle Cells From Blood or Skin Cells of Breast Cancer Patients
Memorial Sloan Kettering Cancer Center
Recruiting
NCT04737265 2025-07-03
NTproBNP-Guide
Abramson Cancer Center at Penn Medicine
Phase 1/2 Completed
NCT07041827 2025-06-27
CLARITY
The Netherlands Cancer Institute
Completed